Designer Diagnostics NanoLogix, Inc. Presents at the National Hydrogen
Association Conference & Provides Operations, Management and
Director Update
HUBBARD, Ohio, March 31, 2008 /PRNewswire-FirstCall via COMTEX/ --
NanoLogix, Inc. (OTC: NNLX - News) a nano-biotechnology company is pleased
to provide the following updates on company events:
NanoLogix personnel are manning a booth and presenting at the
National Hydrogen Association Expo in Sacramento this week, with the
company being represented by William Hartman and Chris Novak. Mr. Hartman
will be presenting in the Exhibition Hall today, March 31, from 2:00-2:30 pm,
on "Biohydrogen and Electricity Production from Waste Water".
Company CEO Bret Barnhizer was Marlene Bourne's guest on The Bourne
Report March 16, on the topic of Hydrogen Power. The interview
provides updates on hydrogen bioreactor operations.
Access: http://www.bournereport.com/radio.php
Work on BNC and BNP development for fast microorganism detection is
proceeding at a rapid pace, with a new patent application filed in March
and positive developments with both the Departments of Defense and Homeland
Security in late February.
Director and Management changes: Dr. Robert Ollar and John Chatterton
have joined the Board of Directors. Dr. Ollar is cofounder of NanoLogix
(as Infectech), the primary author of the majority of the company's granted
patents, and returns to the company after a six year hiatus. Mr. Chatterton
is former co-host of the History Channel series, Deep Sea Detectives, and is
one of the world's most accomplished and well known underwater explorers.
David Barnhizer has joined the company as General Counsel, bringing to the
company nearly forty years of legal expertise. Detailed director and management
team information can be accessed at: http://www.nanologixinc.com/index-2.html
General Counsel David Barnhizer stated: "NNLX is poised to make a
significant move forward under its new board of directors and management
team headed by CEO and Board Chairman Bret Barnhizer and complemented by
a reformed and greatly strengthened board of directors. A skilled and
knowledgeable team of professionals whose members are fully dedicated
to the advancement of NanoLogix has been put into place. As NNLX General
Counsel I am extremely pleased to be associated with a group of professionals
committed to the building of an exceptional company whose patented
technologies are on the cutting edge of hydrogen energy extraction from
industrial and commercial wastes, as well as diagnostic tools that are
drawing the attention of governmental and commercial institutions."
The company has accepted the resignations of directors
Hartman, Allan, and Cavallo from all positions held. Mr. Hartman
will continue to provide business consulting services to NanoLogix.
About NanoLogix, Inc.
NanoLogix is a leading innovator in the research, development,
and commercialization of nano-biotechnologies, applications and
processes. The Company has 31 granted Patents and multiple Patents
Pending for bioreactor- based Hydrogen Production, revolutionary
rapid medical testing technologies, and bioremediation. Information
on NanoLogix is available at
www.nanologixinc.com.
This press release contains statements, which may constitute
"forward- looking statements" within the meaning of the Securities
Act of 1933 and the Securities Exchange Act of 1934, as amended by
the Private Securities Litigation Reform Act of 1995. Those statements
include statements regarding the intent, belief or current expectations
of NanoLogix, Inc., and members of its management as well as the
assumptions on which such statements are based. Prospective investors
are cautioned that any such forward-looking statements are not
guarantees of future performance and involve risks and uncertainties,
and that actual results may differ materially from those contemplated
by such forward-looking statements. The Company undertakes no obligation
to update or revise forward-looking statements to reflect changed
assumptions, the occurrence of unanticipated events or changes to
future operating results.
________________________________________
Contact:
NanoLogix, Inc.
Investor Relations
Bret Barnhizer, CEO
Telephone: 330-534-0800
E-mail:
Bret@nanologixinc.com
